Red Flags Identification during Sponsors' Due Diligence_JML-20221221
分类：Newsletters
香港上市規則講座系列 – 上市公司如何避免簽署合營合同時因其中的退出合營企業機制(暫無法確定對價)被視爲重大交易，而需要取得股東大會批准
香港上市規則講座系列
上市公司如何避免簽署合營合同時因其中的退出合營企業機制(暫無法確定對價)被視爲重大交易，而需要取得股東大會批准
Lectures on Listing Rules_20210930_c如何增加香港生物科技企業上市制度的市場公信力
Is Hong Kong’s Listing Regime for Biotech Companies Viable? – Practicalities for Giving Credence to Listings under the New Chapter 18A of the Listing Rules
Biotech Listing Credance Enhancement 20180602香港股票市場的重新定位
香港聯交所發布關于首次公開招股的靈活定價機制
SEHK’s Proposal to Reform the Independent Directors Regime and Strengthen the Corporate Governance of Listed Companies
聯交所對控股股東連續性要求出具新指引
SFC and HKEX Released Joint Consultation Conclusions on Listing Regulation
New Disclosure of Interests Online System (DION System)
JML就港交所創新板之諮詢函的建議
香港證監會對於持牌法團的新要求
港交所實質性修改上市規則並創設新板
“債券通”對香港資本市場的影響
Risk-based ESG Reporting
Propositions of Crowdfunding Regime in Hong Kong – Part II
Propositions of Crowdfunding Regime in Hong Kong – Part I
Use of Advertisement and Guides for Prospectuses in Hong Kong